Therabron Therapeutics' Series B Round

Therabron Therapeutics raised a round of funding on December 18, 2014.

Therabron Therapeutics, forrmerly Clarassance, is a clinical-stage biotechnology company that develops protein drugs to treat respiratory diseases. The company's products aim to restore the natural im…

Articles about Therabron Therapeutics' Series B Round: